Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Mobility Deficits Assessed With Mobile Technology: What Can We Learn From Brain Iron-Altered Animal Models?

Hopfner F, Hobert MA, Maetzler C, Hansen C, Pham MH, Moreau C, Berg D, Devos D, Maetzler W; Fair-Park II study group.

Front Neurol. 2019 Aug 8;10:833. doi: 10.3389/fneur.2019.00833. eCollection 2019. Review.

PMID:
31440200
2.

Four-repeat tauopathies.

Rösler TW, Tayaranian Marvian A, Brendel M, Nykänen NP, Höllerhage M, Schwarz SC, Hopfner F, Koeglsperger T, Respondek G, Schweyer K, Levin J, Villemagne VL, Barthel H, Sabri O, Müller U, Meissner WG, Kovacs GG, Höglinger GU.

Prog Neurobiol. 2019 Sep;180:101644. doi: 10.1016/j.pneurobio.2019.101644. Epub 2019 Jun 22. Review.

PMID:
31238088
3.

Use of β2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease.

Hopfner F, Wod M, Höglinger GU, Blaabjerg M, Rösler TW, Kuhlenbäumer G, Christensen K, Deuschl G, Pottegård A.

Neurology. 2019 Jul 9;93(2):e135-e142. doi: 10.1212/WNL.0000000000007694. Epub 2019 May 24.

PMID:
31127070
4.

Subgroups of monocytes predict cardiovascular events in patients with coronary heart disease.The PHAMOS trial (Prospective Halle Monocytes Study).

Höpfner F, Jacob M, Ulrich C, Russ M, Simm A, Silber RE, Girndt M, Noutsias M, Werdan K, Schlitt A.

Hellenic J Cardiol. 2019 May 2. pii: S1109-9666(18)30426-3. doi: 10.1016/j.hjc.2019.04.012. [Epub ahead of print]

5.

No association between Parkinson disease and autoantibodies against NMDA-type glutamate receptors.

Hopfner F, Müller SH, Steppat D, Miller J, Schmidt N, Wandinger KP, Leypoldt F, Berg D, Franke A, Lieb W, Tittmann L, Balzer-Geldsetzer M, Baudrexel S, Dodel R, Hilker-Roggendorf R, Kalbe E, Kassubek J, Klockgether T, Liepelt-Scarfone I, Mollenhauer B, Neuser P, Reetz K, Riedel O, Schulte C, Schulz JB, Spottke A, Storch A, Trenkwalder C, Wittchen HU, Witt K, Wüllner U, Deuschl G, Kuhlenbäumer G.

Transl Neurodegener. 2019 Apr 3;8:11. doi: 10.1186/s40035-019-0153-0. eCollection 2019.

6.

Biomarkers of Parkinson's disease: 20 years later.

Yilmaz R, Hopfner F, van Eimeren T, Berg D.

J Neural Transm (Vienna). 2019 Jul;126(7):803-813. doi: 10.1007/s00702-019-02001-3. Epub 2019 Apr 4. Review.

PMID:
30949837
7.

Progress of Pharmacological Approaches in Parkinson's Disease.

Zeuner KE, Schäffer E, Hopfner F, Brüggemann N, Berg D.

Clin Pharmacol Ther. 2019 May;105(5):1106-1120. doi: 10.1002/cpt.1374. Epub 2019 Mar 22.

PMID:
30661251
8.

[Genetics of tremor].

Kuhlenbäumer G, Hopfner F.

Nervenarzt. 2018 Apr;89(4):416-422. doi: 10.1007/s00115-017-0478-9. Review. German.

PMID:
29327099
9.

c.207C>G mutation in sepiapterin reductase causes autosomal dominant dopa-responsive dystonia.

Shalash AS, Rösler TW, Müller SH, Salama M, Deuschl G, Müller U, Opladen T, Petersen BS, Franke A, Hopfner F, Kuhlenbäumer G, Höglinger GU.

Neurol Genet. 2017 Nov 1;3(6):e197. doi: 10.1212/NXG.0000000000000197. eCollection 2017 Dec.

10.

Is essential tremor a single entity?

Hopfner F, Deuschl G.

Eur J Neurol. 2018 Jan;25(1):71-82. doi: 10.1111/ene.13454. Epub 2017 Oct 16. Review.

PMID:
28905504
11.

The etiology of essential tremor: Genes versus environment.

Hopfner F, Helmich RC.

Parkinsonism Relat Disord. 2018 Jan;46 Suppl 1:S92-S96. doi: 10.1016/j.parkreldis.2017.07.014. Epub 2017 Jul 17. Review.

PMID:
28735798
12.

Rest tremor revisited: Parkinson's disease and other disorders.

Chen W, Hopfner F, Becktepe JS, Deuschl G.

Transl Neurodegener. 2017 Jun 16;6:16. doi: 10.1186/s40035-017-0086-4. eCollection 2017. Review.

13.

Gut microbiota in Parkinson disease in a northern German cohort.

Hopfner F, Künstner A, Müller SH, Künzel S, Zeuner KE, Margraf NG, Deuschl G, Baines JF, Kuhlenbäumer G.

Brain Res. 2017 Jul 15;1667:41-45. doi: 10.1016/j.brainres.2017.04.019. Epub 2017 May 12.

PMID:
28506555
14.

Topography of essential tremor.

Chen W, Hopfner F, Szymczak S, Granert O, Müller SH, Kuhlenbäumer G, Deuschl G.

Parkinsonism Relat Disord. 2017 Jul;40:58-63. doi: 10.1016/j.parkreldis.2017.04.012. Epub 2017 Apr 20.

PMID:
28442304
15.

Genome-wide association study in essential tremor identifies three new loci.

Müller SH, Girard SL, Hopfner F, Merner ND, Bourassa CV, Lorenz D, Clark LN, Tittmann L, Soto-Ortolaza AI, Klebe S, Hallett M, Schneider SA, Hodgkinson CA, Lieb W, Wszolek ZK, Pendziwiat M, Lorenzo-Betancor O, Poewe W, Ortega-Cubero S, Seppi K, Rajput A, Hussl A, Rajput AH, Berg D, Dion PA, Wurster I, Shulman JM, Srulijes K, Haubenberger D, Pastor P, Vilariño-Güell C, Postuma RB, Bernard G, Ladwig KH, Dupré N, Jankovic J, Strauch K, Panisset M, Winkelmann J, Testa CM, Reischl E, Zeuner KE, Ross OA, Arzberger T, Chouinard S, Deuschl G, Louis ED, Kuhlenbäumer G, Rouleau GA.

Brain. 2016 Dec;139(Pt 12):3163-3169. Epub 2016 Oct 20.

16.

Knowledge gaps and research recommendations for essential tremor.

Hopfner F, Haubenberger D, Galpern WR, Gwinn K, Van't Veer A, White S, Bhatia K, Adler CH, Eidelberg D, Ondo W, Stebbins GT, Tanner CM, Helmich RC, Lenz FA, Sillitoe RV, Vaillancourt D, Vitek JL, Louis ED, Shill HA, Frosch MP, Foroud T, Kuhlenbäumer G, Singleton A, Testa CM, Hallett M, Elble R, Deuschl G.

Parkinsonism Relat Disord. 2016 Dec;33:27-35. doi: 10.1016/j.parkreldis.2016.10.002. Epub 2016 Oct 4. Review.

17.

Early- and late-onset essential tremor patients represent clinically distinct subgroups.

Hopfner F, Ahlf A, Lorenz D, Klebe S, Zeuner KE, Kuhlenbäumer G, Deuschl G.

Mov Disord. 2016 Oct;31(10):1560-1566. doi: 10.1002/mds.26708.

PMID:
27384030
18.

RAB39B mutations are a rare finding in Parkinson disease patients.

Löchte T, Brüggemann N, Vollstedt EJ, Krause P, Domingo A, Rosales R, Lee LV, Hopfner F, Westenberger A, Kühn A, Klein C, Lohmann K.

Parkinsonism Relat Disord. 2016 Feb;23:116-7. doi: 10.1016/j.parkreldis.2015.12.014. Epub 2015 Dec 22. No abstract available.

PMID:
26739247
19.

Ivabradine in Combination with Metoprolol Improves Symptoms and Quality of Life in Patients with Stable Angina Pectoris: A post hoc Analysis from the ADDITIONS Trial.

Werdan K, Ebelt H, Nuding S, Höpfner F, Stöckl G, Müller-Werdan U; ADDITIONS Study Investigators.

Cardiology. 2016;133(2):83-90. doi: 10.1159/000439584. Epub 2015 Oct 27.

PMID:
26501486
20.

HTLV-1 associated myelopathy after renal transplantation.

Gövert F, Krumbholz A, Witt K, Hopfner F, Feldkamp T, Korn K, Knöll A, Jansen O, Deuschl G, Fickenscher H.

J Clin Virol. 2015 Nov;72:102-5. doi: 10.1016/j.jcv.2015.09.010. Epub 2015 Oct 9. No abstract available.

PMID:
26479201
21.

Validation of the QUEST for German-speaking countries.

Hopfner F, Nebel A, Lyons KE, Tröster AI, Kuhlenbäumer G, Deuschl G, Martinez-Martin P.

Int J Neurosci. 2016;126(2):127-34. doi: 10.3109/00207454.2015.1077241. Epub 2015 Aug 25.

PMID:
26327253
22.

Mystery surrounding DYT2 dystonia now solved: HPCA mutations identified in DYT2-like family.

Hopfner F, Schneider SA.

Mov Disord. 2015 Jul;30(8):1035. doi: 10.1002/mds.26288. Epub 2015 Jun 22. No abstract available.

PMID:
26095160
23.

Testing for alcohol sensitivity of tremor amplitude in a large cohort with essential tremor.

Hopfner F, Erhart T, Knudsen K, Lorenz D, Schneider SA, Zeuner KE, Deuschl G, Kuhlenbäumer G.

Parkinsonism Relat Disord. 2015 Aug;21(8):848-51. doi: 10.1016/j.parkreldis.2015.05.005. Epub 2015 May 14.

PMID:
26002382
24.

Mutations in HTRA2 are not a common cause of familial classic ET.

Hopfner F, Müller SH, Lorenz D, Appenzeller S, Klebe S, Deuschl G, Kuhlenbäumer G.

Mov Disord. 2015 Jul;30(8):1149-50. doi: 10.1002/mds.26252. Epub 2015 May 13. No abstract available.

PMID:
25970799
25.

Ivabradine in combination with Beta-blockers in patients with chronic stable angina after percutaneous coronary intervention.

Werdan K, Ebelt H, Nuding S, Höpfner F, Stöckl G, Müller-Werdan U.

Adv Ther. 2015 Feb;32(2):120-37. doi: 10.1007/s12325-015-0182-8. Epub 2015 Feb 17.

26.

The impact of rare variants in FUS in essential tremor.

Hopfner F, Stevanin G, Müller SH, Mundwiller E, Bungeroth M, Durr A, Pendziwiat M, Anheim M, Schneider SA, Tittmann L, Klebe S, Lorenz D, Deuschl G, Brice A, Kuhlenbäumer G.

Mov Disord. 2015 Apr 15;30(5):721-4. doi: 10.1002/mds.26145. Epub 2015 Jan 28.

PMID:
25631824
27.

The Co-Occurrence of Tricho-Rhino-Phalangeal Syndrome and Early-Onset Levodopa-Sensitive Parkinsonism.

Hopfner F, Caliebe A, Deuschl G, Schneider SA.

Mov Disord Clin Pract. 2014 Sep 24;1(4):379-380. doi: 10.1002/mdc3.12085. eCollection 2014 Dec. No abstract available.

28.

Ivabradine in combination with beta-blocker reduces symptoms and improves quality of life in elderly patients with stable angina pectoris: age-related results from the ADDITIONS study.

Müller-Werdan U, Stöckl G, Ebelt H, Nuding S, Höpfner F, Werdan K; ADDITIONS Study Investigators.

Exp Gerontol. 2014 Nov;59:34-41.

PMID:
25193811
29.

Examination of Patients with Essential Tremor.

Hopfner F, Deuschl G.

Mov Disord Clin Pract. 2014 Apr 10;1(1):87. doi: 10.1002/mdc3.12012. eCollection 2014 Apr.

30.

ALS2 mutations: juvenile amyotrophic lateral sclerosis and generalized dystonia.

Sheerin UM, Schneider SA, Carr L, Deuschl G, Hopfner F, Stamelou M, Wood NW, Bhatia KP.

Neurology. 2014 Mar 25;82(12):1065-7. doi: 10.1212/WNL.0000000000000254. Epub 2014 Feb 21.

31.

Genetics of essential tremor: meta-analysis and review.

Kuhlenbäumer G, Hopfner F, Deuschl G.

Neurology. 2014 Mar 18;82(11):1000-7. doi: 10.1212/WNL.0000000000000211. Epub 2014 Feb 14. Review.

PMID:
24532269
32.

Rare variants in ANO3 are not a susceptibility factor in essential tremor.

Hopfner F, Bungeroth M, Pendziwiat M, Tittmann L, Deuschl G, Schneider SA, Kuhlenbäumer G.

Parkinsonism Relat Disord. 2014 Jan;20(1):134-5. doi: 10.1016/j.parkreldis.2013.09.022. Epub 2013 Sep 27. No abstract available.

PMID:
24094724
33.

The role of SCARB2 as susceptibility factor in Parkinson's disease.

Hopfner F, Schulte EC, Mollenhauer B, Bereznai B, Knauf F, Lichtner P, Zimprich A, Haubenberger D, Pirker W, Brücke T, Peters A, Gieger C, Kuhlenbäumer G, Trenkwalder C, Winkelmann J.

Mov Disord. 2013 Apr;28(4):538-40. doi: 10.1002/mds.25349. Epub 2013 Feb 13.

PMID:
23408458
34.

No association between polymorphisms in the glutamate transporter SLC1A2 and Parkinson's disease.

Appenzeller S, Schulte C, Thier S, Hopfner F, Pendziwiat M, Papengut F, Klein C, Hagenah J, Kasten M, Srulijes K, Berg D, Gasser T, Singleton A, Deuschl G, Kuhlenbäumer G.

Mov Disord. 2013 Aug;28(9):1305-6. doi: 10.1002/mds.25330. Epub 2013 Feb 6. No abstract available.

35.

Ivabradine in combination with beta-blocker improves symptoms and quality of life in patients with stable angina pectoris: results from the ADDITIONS study.

Werdan K, Ebelt H, Nuding S, Höpfner F, Hack G, Müller-Werdan U.

Clin Res Cardiol. 2012 May;101(5):365-73. doi: 10.1007/s00392-011-0402-4. Epub 2012 Jan 10.

PMID:
22231643
36.

Novel SCARB2 mutation in action myoclonus-renal failure syndrome and evaluation of SCARB2 mutations in isolated AMRF features.

Hopfner F, Schormair B, Knauf F, Berthele A, Tölle TR, Baron R, Maier C, Treede RD, Binder A, Sommer C, Maihöfner C, Kunz W, Zimprich F, Heemann U, Pfeufer A, Näbauer M, Kääb S, Nowak B, Gieger C, Lichtner P, Trenkwalder C, Oexle K, Winkelmann J.

BMC Neurol. 2011 Oct 27;11:134. doi: 10.1186/1471-2377-11-134.

37.

Co-aggregate formation of CADASIL-mutant NOTCH3: a single-particle analysis.

Duering M, Karpinska A, Rosner S, Hopfner F, Zechmeister M, Peters N, Kremmer E, Haffner C, Giese A, Dichgans M, Opherk C.

Hum Mol Genet. 2011 Aug 15;20(16):3256-65. doi: 10.1093/hmg/ddr237. Epub 2011 May 30.

PMID:
21628316

Supplemental Content

Loading ...
Support Center